Inside Exact Sciences’ $2.8B Genomic Health buy: A false start, rejections and a mysterious last-minute party


A late Friday SEC filing provides new details into the deal.

Previous HCA and Amazon are both investing in this technology
Next Canon-Mac parents want deeper investigation of suspected childhood cancer cluster

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *